Skip to content

IB Acquisition Corp. (IBAC) Company Overview

Company Analysis

IB Acquisition Corp. IBAC

A comprehensive view of key metrics, scores, and financial health for IB Acquisition Corp.

Overview of IB Acquisition Corp.

IBAC NGM
Financial Services Shell Companies Micro Cap
IB Acquisition Corp. (IBAC), is a Micro Cap company, in the Shell Companies industry, last closed at $10.81, about 0.0% overvalued vs fair value, +4.3% 1Y return, ranked 679/1037 in sector.
Metrics P/E 47.7× ROE 5.1% Div Yield 3.10%
$10.81
0.09%
As of April 28, 2026
Previous close • Vol 90d: 6.3%
52-Week Range
Market Cap
$62.05M
Enterprise Value
$62.03M
Overall Score
Overall
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Good
Valuation
Fair
Growth
Weak
Profitability
Fair
Health
Fair
Efficiency
Good
Valuation
Fair
Completeness: 70%
Confidence: 36%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

HQ Boca Raton, FL
Fiscal year Sep 30

Next Events

No upcoming events available.

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Biotech / Pre-Revenue - Where revenue goes and how value is created

Flow Steps
Cash on Hand
$428.7K
-47.9%%
Total Revenue
$0
Net Income
$3.4M
82.9%%
Operating Expense
$748.9K
42.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Biotech / Pre-Revenue

Quality & Reliability Indicators

Cash Runway
3.9 months
Poor

Critical: Cash runway under 12 months

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$111.3M
25953.3% of Cash on Hand

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Corporate Default

Competitive Advantage Assessment

Evaluating IB Acquisition Corp.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
47
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power

Weak
0
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Pre-Revenue Biotech vs Sector Peers 60% Coverage
Trade-Off Triangle Visualization A ternary plot showing IBAC's balance between Growth (32.1%), Profitability (25.3%), and Safety (42.6%). Growth 32% Safety 43% Profitability 25%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

42th percentile vs peers
42
Key Signals
TSR 8.5% 42p
  • Cash to Debt Ratio in top 20% of peers (1.05, 88th percentile)
  • Strong liquidity position vs peers

No significant risks identified for this axis.

Profitability

- vs peers
-
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

56th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for IB Acquisition Corp..

Loading scenario defaults...
Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info